Back to results
US 9,579,365 B2Granted
Therapeutic ribonucleases
AssigneeQuintessence Biosciences, Inc.
InventorsTony Klink, John Kink, Laura Strong
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of ribonucleases (RNases) in the treatment or prevention of disease.
Claims16
A method for treating a subject, comprising administering to a subject a composition comprising a ribonuclease having:
- i) a human RNase 1 amino acid sequence with at least 95% sequence identity to SEQ ID NO:1, ii) a cysteine at the position corresponding to position 4 of SEQ ID NO:1, iii) an arginine at the position corresponding to position 38 of SEQ ID NO:1, iv) a glycine at the position corresponding to position 39 of SEQ ID NO:1, v) an arginine at the position corresponding to position 67 of SEQ ID NO:1, vi) an arginine at the position corresponding to position 89 of SEQ ID NO:1, vii) an arginine at the position corresponding to position 90 of SEQ ID NO:1, and viii) a cysteine at the position corresponding to position 118 of SEQ ID NO:1.
Dependencies are inferred from the claim text.